Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less innovative health care systems.” ...

Bristol Myers Squibb CEO Chris Boerner described his company's new drug, Cobenfy, which can be used to treat psychiatric disorders like schizophrenia, saying the treatment is effective without the ...

Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the pharmaceutical company. The New Jersey-based company posted a net loss of $8. ...

The company's new CEO spent nearly 30 years at Bristol Myers Squibb, and recently led another Boston biotech that was acquired by Ipsen. Boston Business Journal Select a City ...